By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


FORUM Pharmaceuticals (Formerly Known As EnVivo Pharmaceuticals, Inc.) 

480 Arsenal Street
Building 1
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-225-4250 Fax: 617-225-4267


Drug Discovery

Company News
FORUM Pharmaceuticals To Participate In Needham & Company’s 14th Annual Healthcare Conference 4/8/2015 10:03:43 AM
FORUM Pharmaceuticals To Participate In Suntrust Robinson Humphrey 2015 Biotechnology And Pharmaceutical Orphan Drug Day 2/18/2015 1:55:36 PM
FORUM Pharmaceuticals To Present At Leerink Global Healthcare Conference 2/11/2015 12:51:15 PM
FORUM Pharmaceuticals Initiates Phase 2a Clinical Trial Of FRM-0334 In Frontotemporal Dementia With GRN Mutation 2/10/2015 10:41:43 AM
FORUM Pharmaceuticals Presents FRM-0334 Studies At 9th International Conference On Frontotemporal Dementias 10/29/2014 8:55:40 AM
FORUM Pharmaceuticals Appoints Christine Boisclair As Vice President, Regulatory Affairs 7/9/2014 11:03:15 AM
FORUM Pharmaceuticals Appoints Todd Shegog As Chief Financial Officer 4/22/2014 7:03:01 AM
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals 4/2/2014 8:46:12 AM
EnVivo Pharmaceuticals, Inc. Initiates COGNITIV AD, A Phase 3 Clinical Trial Program Of Encenicline (EVP-6124) In Alzheimer’s Disease 1/22/2014 9:24:17 AM
Ex-Millennium: The Takeda Oncology Company CEO to Head EnVivo Pharmaceuticals, Inc. 7/11/2013 7:15:42 AM